Jam Surgical Company Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 15-11-2024
- Paid Up Capital ₹ 0.30 M
as on 15-11-2024
- Company Age 12 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 Cr
as on 15-11-2024
- Satisfied Charges ₹ 6.60 Cr
as on 15-11-2024
- Revenue 44.71%
(FY 2023)
- Profit 48.23%
(FY 2023)
- Ebitda 63.55%
(FY 2023)
- Net Worth -3.98%
(FY 2023)
- Total Assets -9.64%
(FY 2023)
About Jam Surgical Company
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹5.00 Cr. The company has closed loans amounting to ₹6.60 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nikita Kapoor, Mohit Bajaj, and Jyothi Bajaj serve as directors at the Company.
- CIN/LLPIN
U74999TN2012PTC087381
- Company No.
087381
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Aug 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Jam Surgical Company?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohit Bajaj  | Director | 27-Aug-2012 | Current |
| Nikita Kapoor | Director | 09-Oct-2018 | Current |
| Jyothi Bajaj | Director | 27-Aug-2012 | Current |
Financial Performance of Jam Surgical Company.
Jam Surgical Company Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 44.71% increase. The company also saw a substantial improvement in profitability, with a 48.23% increase in profit. The company's net worth dipped by a decrease of 3.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jam Surgical Company?
In 2023, Jam Surgical Company had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Niaara Healthcare Private LimitedActive 11 years 2 monthsMohit Bajaj and Jyothi Bajaj are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 30 Dec 2014 | ₹5.00 Cr | Open |
Punjab & Sind Bank Creation Date: 17 Jun 2013 | ₹6.60 Cr | Satisfied |
How Many Employees Work at Jam Surgical Company?
Jam Surgical Company has a workforce of 39 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jam Surgical Company, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jam Surgical Company's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
